Majority of children affected by allergy-related diseases

March 28, 2012
Majority of children affected by allergy-Related diseases
A majority of children have one or more allergy-related diseases, including eczema, asthma, and rhinitis, according to research published in the April issue of Allergy.

(HealthDay) -- A majority of children have one or more allergy-related diseases, including eczema, asthma, and rhinitis, according to research published in the April issue of Allergy.

Natalia Ballardini, M.D., of the Karolinska Institutet in Stockholm, and colleagues conducted a population-based cohort study that involved surveying the parents of 2,916 children at age 1, 2, 4, 8, and 12 regarding eczema, , and rhinitis development during childhood.

At 12 years, the researchers found that 58 percent of the children had experienced eczema, asthma, and/or rhinitis at some point during their childhood, and 7.5 percent of the children had at least two of these allergy-related diseases. Children of parents with allergies were more likely to have any allergy-related disease (adjusted odds ratio, 1.76) as well as comorbidity and more persistent disease. Throughout childhood, there was an increased risk associated with male gender. There were no gender differences in disease persistence, and minor differences were found for comorbidity.

"We found that allergy-related diseases affect a majority of the pediatric population during the first 12 years of life and that the development of , asthma, and rhinitis is a dynamic process: both new cases and are common throughout childhood," the authors write.

Explore further: Allergy-Related diseases affect majority of children

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Allergy-Related diseases affect majority of children

February 25, 2012
(HealthDay) -- Eczema, asthma, and rhinitis affect more than 50 percent of children up to age 12, according to a study published online Feb. 16 in Allergy.

Childhood eczema and hay fever leads to adult allergic asthma

April 15, 2011
(PhysOrg.com) -- Children who have eczema, particularly when occurring with hay fever, are nine times more likely to develop allergic asthma in their 40s, a new study reveals.

Recommended for you

New compound discovered in fight against inflammatory disease

September 22, 2017
A 10-year study by University of Manchester scientists for a new chemical compound that is able to block a key component in inflammatory illness has ended in success.

Asthma researchers test substance from coralberry leaves

September 14, 2017
The coralberry could offer new hope for asthmatics. Researchers at the University of Bonn have extracted an active pharmaceutical ingredient from its leaves to combat asthma, a widespread respiratory disease. In mice, it ...

Respiratory experts urge rethink of 'outdated' asthma categorisation

September 12, 2017
A group of respiratory medicine experts have called for an overhaul of how asthma and other airways diseases are categorised and treated.

New 'biologic' drug may help severe asthma

September 7, 2017
(HealthDay)—A "biologic" drug in development to treat severe asthma reduces the rate of serious attacks by about two-thirds compared to a placebo drug, according to preliminary research findings.

Songbird study shows how estrogen may stop infection-induced brain inflammation

August 31, 2017
The chemical best-known as a female reproductive hormone—estrogen—could help fight off neurodegenerative conditions and diseases in the future. Now, new research by American University neuroscience Professor Colin Saldanha ...

New insights into protein's role in inflammatory response

July 28, 2017
A protein called POP2 inhibits a key inflammatory pathway, calming the body's inflammatory response before it can become destructive, Northwestern Medicine scientists have demonstrated in mouse models.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.